Suchergebnisse - "Sessa, C"

PubPharm (422)

11

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

12

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

13

ESMO-ESGO consensus conference recommendations on ovarian cancer : pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2019

von Colombo, N. | Sessa, C. | Bois, A. | +60

14

ESMO-ESGO consensus conference recommendations on ovarian cancer : pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Colombo, N. | Sessa, C. | du Bois, A. | +61

15

Convective Dialysis Reduces Mortality Risk : Results From a Large Observational, Population-Based Analysis

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2018

von Cernaro, V. | Tripepi, G. | Visconti, L. | +109

16

Newly diagnosed and relapsed epithelial ovarian carcinoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Ledermann, J. | Raja, F. | Fotopoulou, C. | +4

ErratumFor: Ann Oncol. 2013 Oct;24 Suppl 6:vi24-32. - PMID 24078660

17

Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores

enthalten in: Cancer treatment reviews | 2018

von Broekman, K. | Jalving, M. | van Tinteren, H. | +2

18

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +13

19

Appendix 5 : Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Colombo, N. | Creutzberg, C. | Querleu, D. | +3

20

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +12